A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma

CompletedOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

October 10, 2024

Study Completion Date

October 10, 2024

Conditions
Renal Cell Carcinoma, Clear Cell
Trial Locations (1)

200120

Renji Hospital, Shanghai

All Listed Sponsors
collaborator

The First Affiliated Hospital of Anhui Medical University

OTHER

collaborator

The Fourth Affiliated Hospital of Harbin Medical University

OTHER

collaborator

Second Affiliated Hospital of Soochow University

OTHER

collaborator

Qianfoshan Hospital

OTHER

collaborator

Chang Gung Memorial Hospital

OTHER

lead

RenJi Hospital

OTHER

NCT06656039 - A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter